drugset / Trial / NCT07487246

Paracervical Block With Combined Ketorolac and Lidocaine for Osmotic Dilator Placement

NCT07487246

Phase 2 Recruiting 76 enrolled Rush University Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to improve pain management for participantswho need osmotic dilators for cervical preparation the day before their second trimester abortion procedure.

Timeline

Start
2026-06-29
Primary completion
2027-04-30
Completion
2027-04-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ibuprofen Small molecule 600 mg Oral
Subject Ketorolac Other / unclassified 30 mg Other
Background Lidocaine Other / unclassified 1 % Other

Indications

No indication recorded.